share_log
Moomoo 24/7 ·  Mar 28 07:03
Syndax Disclosed Completion Of Enrollment In AUGMENT-101 Pivotal Trial Cohort Of Patients With Relapsed/Refractory MNPM1 Acute Myeloid Leukemia & Expects Topline Data In Q1 2024
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment